Nephrocare Health Services Limited has informed the Exchange about Giving guarantees/indemnity/ becoming a surety for third party

Nephrocare Health Services reported Q4 FY26 standalone revenue of Rs 1,643.33 million with profit before tax of Rs 109.93 million. For the full year FY26, the company reported a loss before tax of Rs 37.69 million compared to a profit of Rs 453.60 million in FY25, primarily due to a non-cash, non-recurring interest expense of Rs 371.89 million on FVTPL financial liabilities. The Board approved investment of up to Rs 10 crore in its Nepal subsidiary and granted in-principal approval for providing collateral/security support of up to Rs 70 crore each for its Singapore and Saudi Arabia subsidiaries to help them secure credit facilities from overseas banks. BDO India LLP was re-appointed as internal auditor for FY 2026-27. The company listed on NSE and BSE in December 2025 via an IPO. Cash position improved significantly to Rs 936.78 million from Rs 38.54 million, while total equity grew to Rs 9,709.06 million.